Yuan Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuan Yang has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Qing Mao
Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China
10 shared publications Tao Chang
Department of Critical care medicine, West China Hospital, Sichuan University
8 shared publications- Yanhui Liu
Guangdong Medical University, China
8 shared publications Yanhui Liu
Department of Neurosurgery, West China Hospital, Sichuan University
6 shared publicationsSiliang Chen
Department of Neurosurgery, West China Hospital, Sichuan University
5 shared publicationsXiang Wang
Department of Neurosurgery West China Hospital, Sichuan University Chengdu Sichuan China
5 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (43) , eadx5564
Biophysically constrained learning from healthy neural priors improves motor decoding in pathological cortical networks
High-performance brain-computer interfaces (BCIs) rely on stable neural representations, yet brain functional impairments inherently disrupt canonical encoding, creating a fundamental decoding paradox. Conventional data-driven approaches struggle to bridge this gap because of pathological data scarcity and heterogeneity. Here, we propose to leverage healthy neural priors and introduce Pathology-Aware Consensus Training (PACT), a paradigm embedding biophysical constraints into healthy neural recordings to guide neural decoding. In a gesture classification task using high-density electrocorticography from patients with gliomas infiltrating the motor cortex, PACT improved the accuracy by more than 10%, effectively restoring the distorted semantic geometry of motor commands and realigning them with healthy canonical representations (correlation increase: r = 0.66 to r = 0.94). Mechanistically, PACT induced an emergent “inverse weighting” strategy: The model autonomously suppresses high-power pathological noise while reanchoring spatial attention to functional compensatory regions. This study provides a proof of concept for improving decoding in compromised networks by harnessing healthy neural dynamics, laying the theoretical foundation for future BCI deployments in clinical populations.
- 23 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (43) , eadx5564
Open AccessBiophysically constrained learning from healthy neural priors improves motor decoding in pathological cortical networks
High-performance brain-computer interfaces (BCIs) rely on stable neural representations, yet brain functional impairments inherently disrupt canonical encoding, creating a fundamental decoding paradox. Conventional data-driven approaches struggle to bridge this gap because of pathological data scarcity and heterogeneity. Here, we propose to leverage healthy neural priors and introduce Pathology-Aware Consensus Training (PACT), a paradigm embedding biophysical constraints into healthy neural recordings to guide neural decoding. In a gesture classification task using high-density electrocorticography from patients with gliomas infiltrating the motor cortex, PACT improved the accuracy by more than 10%, effectively restoring the distorted semantic geometry of motor commands and realigning them with healthy canonical representations (correlation increase: r = 0.66 to r = 0.94). Mechanistically, PACT induced an emergent “inverse weighting” strategy: The model autonomously suppresses high-power pathological noise while reanchoring spatial attention to functional compensatory regions. This study provides a proof of concept for improving decoding in compromised networks by harnessing healthy neural dynamics, laying the theoretical foundation for future BCI deployments in clinical populations.
- Open Access
- 31 August 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (9) , e72225
Study of Adaptive Radiotherapy for High‐Grade Glioma Based on Interfraction MRI
Background: Currently, there is no clear guidance on the appropriate population or timing for adaptive radiotherapy (ART) in high‐grade glioma (HGG) patients. This study aims to provide individualized ART for HGG patients. Methods: Participants received standard “radiotherapy combined with temozolomide” and underwent MRI before radiotherapy (FX0), after fraction 10 (FX10), and after fraction 20 (FX20). The primary endpoint was anatomical and dosimetric changes in targets and organs at risk (OARs). Results: Among the 73 eligible patients, significant anatomical changes occurred during chemoradiotherapy, particularly at FX10. ART significantly improved target dose coverage and reduced OAR doses compared with projection plans. Univariable and multivariable logistic regression analysis identified Relative volume change (Vrel)_CTV ≥ 7% as an independent risk factor for dosimetric changes, with IDH wild‐type and tumor diameters < 5 cm as independent risk factors. Median follow‐up was 12 months; median progression‐free survival (PFS) was 18 months. D_migration_max_CTV ≥ 8.5 mm was associated with worse PFS. Conclusions: Implementing ART after FX10 is recommended. HGG patients with wild‐type IDH and tumor diameters < 5 cm should be prioritized for ART. Patients with D_migration_max_CTV ≥ 8.5 mm require more intensive treatment. Trial Registration: The trial was prospectively registered ( ClinicalTrials.gov , NCT06201351)
- 31 August 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (9) , e72225
Open AccessStudy of Adaptive Radiotherapy for High‐Grade Glioma Based on Interfraction MRI
Background: Currently, there is no clear guidance on the appropriate population or timing for adaptive radiotherapy (ART) in high‐grade glioma (HGG) patients. This study aims to provide individualized ART for HGG patients. Methods: Participants received standard “radiotherapy combined with temozolomide” and underwent MRI before radiotherapy (FX0), after fraction 10 (FX10), and after fraction 20 (FX20). The primary endpoint was anatomical and dosimetric changes in targets and organs at risk (OARs). Results: Among the 73 eligible patients, significant anatomical changes occurred during chemoradiotherapy, particularly at FX10. ART significantly improved target dose coverage and reduced OAR doses compared with projection plans. Univariable and multivariable logistic regression analysis identified Relative volume change (Vrel)_CTV ≥ 7% as an independent risk factor for dosimetric changes, with IDH wild‐type and tumor diameters < 5 cm as independent risk factors. Median follow‐up was 12 months; median progression‐free survival (PFS) was 18 months. D_migration_max_CTV ≥ 8.5 mm was associated with worse PFS. Conclusions: Implementing ART after FX10 is recommended. HGG patients with wild‐type IDH and tumor diameters < 5 cm should be prioritized for ART. Patients with D_migration_max_CTV ≥ 8.5 mm require more intensive treatment. Trial Registration: The trial was prospectively registered ( ClinicalTrials.gov , NCT06201351)
- Open Access
- 3 August 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1834752
Intraoperative electrocorticography–guided glioma surgery: impact on extent of resection and functional preservation
Objective: Direct cortical stimulation (DCS) remains the gold standard for functional mapping in glioma surgery; however, its reliability may be limited by glioma−induced neural remodeling, incomplete motor mapping, and intraoperative constraints. We investigated whether supplementing DCS with electrocorticography (ECoG) for intraoperative functional mapping and tumor boundary delineation improves extent of resection (EOR) and neurological outcomes in glioma surgeries. Methods: We conducted a single-center retrospective cohort study of 120 adults with supratentorial gliomas who underwent surgery between June 2021 and April 2024. Patients underwent awake or general anesthesia craniotomy with intraoperative mapping using DCS alone or DCS combined with ECoG. They were stratified into four groups: AC−ECoG (awake with DCS only, n=34), AC+ECoG (awake with DCS+ECoG, n=30), GA−ECoG (general anesthesia with DCS only, n=28), and GA+ECoG (general anesthesia with DCS+ECoG, n=28). Intraoperative ECoG was used for both functional mapping and tumor delineation. Multivariable linear regression evaluated ECoG’s independent effect on EOR and 6−month outcomes (KPS, MoCA, MMSE), adjusting for tumor characteristics and patient factors. Descriptive subgroup analyses compared outcomes across anesthesia and mapping modalities. Results: ECoG independently predicted higher EOR (β=3.3, p<0.001) and 6-month KPS (β=5.1, p=0.025), MoCA (β=1.8, p=0.003), and MMSE (β=3.0, p=0.024). Higher Ki−67 (≥10%) predicted lower EOR (β=−2.0, p=0.024). Subgroup analyses further demonstrated this effect, with ECoG-guided surgeries achieving higher EOR, smaller residual volumes, and improved early cognitive outcomes. Conclusion: Intraoperative ECoG independently improves extent of resection and early functional outcomes across anesthesia paradigms, supporting its role as a valuable adjunct to DCS in glioma surgery.
- 3 August 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1834752
Open AccessIntraoperative electrocorticography–guided glioma surgery: impact on extent of resection and functional preservation
Objective: Direct cortical stimulation (DCS) remains the gold standard for functional mapping in glioma surgery; however, its reliability may be limited by glioma−induced neural remodeling, incomplete motor mapping, and intraoperative constraints. We investigated whether supplementing DCS with electrocorticography (ECoG) for intraoperative functional mapping and tumor boundary delineation improves extent of resection (EOR) and neurological outcomes in glioma surgeries. Methods: We conducted a single-center retrospective cohort study of 120 adults with supratentorial gliomas who underwent surgery between June 2021 and April 2024. Patients underwent awake or general anesthesia craniotomy with intraoperative mapping using DCS alone or DCS combined with ECoG. They were stratified into four groups: AC−ECoG (awake with DCS only, n=34), AC+ECoG (awake with DCS+ECoG, n=30), GA−ECoG (general anesthesia with DCS only, n=28), and GA+ECoG (general anesthesia with DCS+ECoG, n=28). Intraoperative ECoG was used for both functional mapping and tumor delineation. Multivariable linear regression evaluated ECoG’s independent effect on EOR and 6−month outcomes (KPS, MoCA, MMSE), adjusting for tumor characteristics and patient factors. Descriptive subgroup analyses compared outcomes across anesthesia and mapping modalities. Results: ECoG independently predicted higher EOR (β=3.3, p<0.001) and 6-month KPS (β=5.1, p=0.025), MoCA (β=1.8, p=0.003), and MMSE (β=3.0, p=0.024). Higher Ki−67 (≥10%) predicted lower EOR (β=−2.0, p=0.024). Subgroup analyses further demonstrated this effect, with ECoG-guided surgeries achieving higher EOR, smaller residual volumes, and improved early cognitive outcomes. Conclusion: Intraoperative ECoG independently improves extent of resection and early functional outcomes across anesthesia paradigms, supporting its role as a valuable adjunct to DCS in glioma surgery.
- 19 February 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (5) , 1365-1376
Unveiling the whole-brain impact of diffuse midline glioma: cortical morphological remodeling and network alterations driven by H3 K27 mutation
- 19 February 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (5) , 1365-1376
Unveiling the whole-brain impact of diffuse midline glioma: cortical morphological remodeling and network alterations driven by H3 K27 mutation
- 29 January 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 167
Strategy of adult thalamic glioma surgery: Thoughts and practices based on thalamic glioma classification
- 29 January 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 167
Strategy of adult thalamic glioma surgery: Thoughts and practices based on thalamic glioma classification
- Open Access
- 30 October 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1681695
The impact of maximized resection and standardized systemic therapy on overall survival in adult patients with thalamic gliomas
Objective: This study aims to explore the impact of maximized resection and standardized systemic surgery + chemoradiotherapy(SRC) on the survival prognosis of adult thalamic glioma, and to construct a clinical prognosis model of adult thalamic glioma. Methods: A retrospective analysis was conducted on adult cases of thalamic glioma who underwent craniotomy in the Department of Neurosurgery of West China Hospital of Sichuan University from 01/03/2009 to 01/03/2024. Firstly, Kaplan-Meier survival analysis and subgroup analysis were conducted. Secondly, COX regression and LASSO-COX regression were performed on 12 variables respectively to screen the variables and construct a prognostic model. Then, the efficacy of different models was compared to select the optimal model to construct a prognostic nomogram for the overall survival of thalamic glioma. Results: Total of 192 adult patients with thalamic glioma were included in this study, of whom 84 underwent surgery only, 41 underwent surgery + radiotherapy/chemotherapy(SR/SC), and 67 completed SRC. Among them, 79 patients(41.1%) completed gross-total tumor resection during the operation, and 113 patients(58.9%) completed non-gross-total tumor resection. The efficacy of the three models was compared. The optimal LASSO-COX model included five variables that affected the overall survival(OS) of thalamic glioma (EOR, diagnosis, preoperative hydrocephalus, postoperative KPS, treatment). Then, these five variables were utilized to develop prognostic nomograms for predicting the 6-, 12-, 24-, 36-, and 60-month OS. The nomogram shows good predictive ability and clinical practicability. Finally, the risk stratification system based on the prognostic nomogram effectively divided patients into the high-risk group and the low-risk group. Conclusions: Maximized tumor resection within safe parameters with standardized systemic SRC significantly prolong the OS of patients with thalamic glioma. The survival prognosis nomogram based on LASSO-COX regression in this study can be used as a practical tool for predicting the survival probability of patients with thalamic glioma.
- 30 October 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1681695
Open AccessThe impact of maximized resection and standardized systemic therapy on overall survival in adult patients with thalamic gliomas
Objective: This study aims to explore the impact of maximized resection and standardized systemic surgery + chemoradiotherapy(SRC) on the survival prognosis of adult thalamic glioma, and to construct a clinical prognosis model of adult thalamic glioma. Methods: A retrospective analysis was conducted on adult cases of thalamic glioma who underwent craniotomy in the Department of Neurosurgery of West China Hospital of Sichuan University from 01/03/2009 to 01/03/2024. Firstly, Kaplan-Meier survival analysis and subgroup analysis were conducted. Secondly, COX regression and LASSO-COX regression were performed on 12 variables respectively to screen the variables and construct a prognostic model. Then, the efficacy of different models was compared to select the optimal model to construct a prognostic nomogram for the overall survival of thalamic glioma. Results: Total of 192 adult patients with thalamic glioma were included in this study, of whom 84 underwent surgery only, 41 underwent surgery + radiotherapy/chemotherapy(SR/SC), and 67 completed SRC. Among them, 79 patients(41.1%) completed gross-total tumor resection during the operation, and 113 patients(58.9%) completed non-gross-total tumor resection. The efficacy of the three models was compared. The optimal LASSO-COX model included five variables that affected the overall survival(OS) of thalamic glioma (EOR, diagnosis, preoperative hydrocephalus, postoperative KPS, treatment). Then, these five variables were utilized to develop prognostic nomograms for predicting the 6-, 12-, 24-, 36-, and 60-month OS. The nomogram shows good predictive ability and clinical practicability. Finally, the risk stratification system based on the prognostic nomogram effectively divided patients into the high-risk group and the low-risk group. Conclusions: Maximized tumor resection within safe parameters with standardized systemic SRC significantly prolong the OS of patients with thalamic glioma. The survival prognosis nomogram based on LASSO-COX regression in this study can be used as a practical tool for predicting the survival probability of patients with thalamic glioma.
- Open Access
- 13 March 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 106
Primary pineal alveolar rhabdomyosarcoma in an adult patient: a case report and literature review
The rarity of adult primary cerebral rhabdomyosarcoma (PCRMS) cases has necessitated the adoption of pediatric rhabdomyosarcoma (RMS) therapeutic protocols, highlighting a critical need for expanded treatment experiences to enhance prognoses. A 21-year-old female presented to our facility with a 20-day history of persistent headache, nausea, and vomiting, along with mild upward gaze palsy for the past 5 to 7 days. A brain magnetic resonance imaging (MRI) revealed a mass in the pineal region, extending into the third ventricle, measuring approximately 2.5 × 2.0 × 3.0 cm. The lesion exhibited mild irregular lobulation and heterogeneous enhancement. Intraoperatively, it displayed characteristics similar to high-grade gliomas, including a grayish appearance, abundant vasculature, firm texture, and indistinct margins adjacent to the bilateral thalamus. Pathology confirmed alveolar PCRMS with FOXO1 gene rearrangement. Whole-body imaging following pathological diagnosis showed no evidence of skull base infiltration or extracranial metastasis. Despite comprehensive multimodal treatment, including surgery, stereotactic radiotherapy, and chemotherapy, tumor recurrence occurred three months after initial surgery, and the patient unfortunately succumbed to the disease eight months after her initial diagnosis. Alveolar PCRMS in the pineal region, a distinct subtype of RMS, is exceptionally rare and typically associated with a bleak prognosis, suggesting unique tumor biology. A multidisciplinary and aggressive management approach is crucial. Further research into the molecular makeup of RMS in adults may pave the way for more effective, tailored treatments for this aggressive disease.
- 13 March 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 106
Open AccessPrimary pineal alveolar rhabdomyosarcoma in an adult patient: a case report and literature review
The rarity of adult primary cerebral rhabdomyosarcoma (PCRMS) cases has necessitated the adoption of pediatric rhabdomyosarcoma (RMS) therapeutic protocols, highlighting a critical need for expanded treatment experiences to enhance prognoses. A 21-year-old female presented to our facility with a 20-day history of persistent headache, nausea, and vomiting, along with mild upward gaze palsy for the past 5 to 7 days. A brain magnetic resonance imaging (MRI) revealed a mass in the pineal region, extending into the third ventricle, measuring approximately 2.5 × 2.0 × 3.0 cm. The lesion exhibited mild irregular lobulation and heterogeneous enhancement. Intraoperatively, it displayed characteristics similar to high-grade gliomas, including a grayish appearance, abundant vasculature, firm texture, and indistinct margins adjacent to the bilateral thalamus. Pathology confirmed alveolar PCRMS with FOXO1 gene rearrangement. Whole-body imaging following pathological diagnosis showed no evidence of skull base infiltration or extracranial metastasis. Despite comprehensive multimodal treatment, including surgery, stereotactic radiotherapy, and chemotherapy, tumor recurrence occurred three months after initial surgery, and the patient unfortunately succumbed to the disease eight months after her initial diagnosis. Alveolar PCRMS in the pineal region, a distinct subtype of RMS, is exceptionally rare and typically associated with a bleak prognosis, suggesting unique tumor biology. A multidisciplinary and aggressive management approach is crucial. Further research into the molecular makeup of RMS in adults may pave the way for more effective, tailored treatments for this aggressive disease.
- Open Access
- 4 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (4) , 2849-2861
Glioma-induced neural functional remodeling in the hand motor cortex: precise mapping with ECoG grids during awake craniotomy
Background: The dilemma of achieving ‘onco-functional balance’ in gliomas affecting the motor cortex highlights the importance of functionally-guided resection strategies. While accurate mapping of eloquent areas often requires frequent electrical stimulation, this practice can lead to side effects like seizures and postoperative deficits. To enhance safety in functional mapping, we studied how gliomas impact hand movement areas and assessed the effectiveness of cortical electrical activity for functional mapping in this setting. Materials and methods: We recruited patients with gliomas affecting the motor cortex and individuals with an unaffected motor cortex for awake craniotomy. During the procedures, electrocorticography (ECoG) grids were employed to record signals under three conditions: resting state, finger movements, and wrist movements. We then quantified the distances from the positively stimulated sites to the specific anatomical landmarks. Additionally, we analyzed the relationship between the ECoG power features and the stimulation responses. Results: The cortical layout for finger activity in the motor cortex glioma (MCG) group was more dispersed and overlapped, typically clustering near the central sulcus and Sylvian fissure. The predictive performance of ECoG mapping exhibited significant variability across different frequency bands and clinical scenarios. Specifically, the area under the curve (AUC) for the non-MCG group during the resting state reached its peak, with a value of 0.802 for Gamma3 (95% CI = 0.729–0.875) and 0.865 for broadband (95% CI = 0.804–0.926). In contrast, the MCG group achieved the highest AUC during wrist movements, with Gamma3 at 0.785 (95% CI = 0.719–0.849) and broadband at 0.824 (95% CI = 0.753–0.890). Conclusion: Gliomas in the motor cortex disrupt the distribution of hand activity, complicating intraoperative functional mapping. As a novel and reliable approach, ECoG technique can complement and guide direct cortical stimulation for precise mapping, potentially reducing its frequency, minimizing the risk of functional deficits, and achieving a balance between maximal tumor resection and neurological preservation.
- 4 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (4) , 2849-2861
Open AccessGlioma-induced neural functional remodeling in the hand motor cortex: precise mapping with ECoG grids during awake craniotomy
Background: The dilemma of achieving ‘onco-functional balance’ in gliomas affecting the motor cortex highlights the importance of functionally-guided resection strategies. While accurate mapping of eloquent areas often requires frequent electrical stimulation, this practice can lead to side effects like seizures and postoperative deficits. To enhance safety in functional mapping, we studied how gliomas impact hand movement areas and assessed the effectiveness of cortical electrical activity for functional mapping in this setting. Materials and methods: We recruited patients with gliomas affecting the motor cortex and individuals with an unaffected motor cortex for awake craniotomy. During the procedures, electrocorticography (ECoG) grids were employed to record signals under three conditions: resting state, finger movements, and wrist movements. We then quantified the distances from the positively stimulated sites to the specific anatomical landmarks. Additionally, we analyzed the relationship between the ECoG power features and the stimulation responses. Results: The cortical layout for finger activity in the motor cortex glioma (MCG) group was more dispersed and overlapped, typically clustering near the central sulcus and Sylvian fissure. The predictive performance of ECoG mapping exhibited significant variability across different frequency bands and clinical scenarios. Specifically, the area under the curve (AUC) for the non-MCG group during the resting state reached its peak, with a value of 0.802 for Gamma3 (95% CI = 0.729–0.875) and 0.865 for broadband (95% CI = 0.804–0.926). In contrast, the MCG group achieved the highest AUC during wrist movements, with Gamma3 at 0.785 (95% CI = 0.719–0.849) and broadband at 0.824 (95% CI = 0.753–0.890). Conclusion: Gliomas in the motor cortex disrupt the distribution of hand activity, complicating intraoperative functional mapping. As a novel and reliable approach, ECoG technique can complement and guide direct cortical stimulation for precise mapping, potentially reducing its frequency, minimizing the risk of functional deficits, and achieving a balance between maximal tumor resection and neurological preservation.
- Open Access
- 11 September 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1447879
Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study
Background: This study aimed to identify prognostic factors for survival and develop a prognostic nomogram to predict the survival probability of elderly patients with lower-grade gliomas (LGGs).Methods: Elderly patients with histologically confirmed LGG were recruited from the Surveillance, Epidemiology, and End Results (SEER) database. These individuals were randomly allocated to the training and validation cohorts at a 2:1 ratio. First, Kaplan−Meier survival analysis and subgroup analysis were performed. Second, variable screening of all 13 variables and a comparison of predictive models based on full Cox regression and LASSO-Cox regression analyses were performed, and the key variables in the optimal model were selected to construct prognostic nomograms for OS and CSS. Finally, a risk stratification system and a web-based dynamic nomogram were constructed.Results: A total of 2307 elderly patients included 1220 males and 1087 females, with a median age of 72 years and a mean age of 73.30 ± 6.22 years. Among them, 520 patients (22.5%) had Grade 2 gliomas, and 1787 (77.5%) had Grade 3 gliomas. Multivariate Cox regression analysis revealed four independent prognostic factors (age, WHO grade, surgery, and chemotherapy) that were used to construct the full Cox model. In addition, LASSO-Cox regression analysis revealed five prognostic factors (age, WHO grade, surgery, radiotherapy, and chemotherapy), and a LASSO model was constructed. A comparison of the two models revealed that the LASSO model with five variables had better predictive performance than the full Cox model with four variables. Ultimately, five key variables based on LASSO-Cox regression were utilized to develop prognostic nomograms for predicting the 1-, 2-, and 5-year OS and CSS rates. The nomograms exhibited relatively good predictive ability and clinical utility. Moreover, the risk stratification system based on the nomograms effectively divided patients into low-risk and high-risk subgroups.Conclusion: Variable screening based on LASSO-Cox regression was used to determine the optimal prediction model in this study. Prognostic nomograms could serve as practical tools for predicting survival probabilities, categorizing these patients into different mortality risk subgroups, and developing personalized decision-making strategies for elderly patients with LGGs. Moreover, the web-based dynamic nomogram could facilitate its use in the clinic.
- 11 September 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1447879
Open AccessVariable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study
Background: This study aimed to identify prognostic factors for survival and develop a prognostic nomogram to predict the survival probability of elderly patients with lower-grade gliomas (LGGs).Methods: Elderly patients with histologically confirmed LGG were recruited from the Surveillance, Epidemiology, and End Results (SEER) database. These individuals were randomly allocated to the training and validation cohorts at a 2:1 ratio. First, Kaplan−Meier survival analysis and subgroup analysis were performed. Second, variable screening of all 13 variables and a comparison of predictive models based on full Cox regression and LASSO-Cox regression analyses were performed, and the key variables in the optimal model were selected to construct prognostic nomograms for OS and CSS. Finally, a risk stratification system and a web-based dynamic nomogram were constructed.Results: A total of 2307 elderly patients included 1220 males and 1087 females, with a median age of 72 years and a mean age of 73.30 ± 6.22 years. Among them, 520 patients (22.5%) had Grade 2 gliomas, and 1787 (77.5%) had Grade 3 gliomas. Multivariate Cox regression analysis revealed four independent prognostic factors (age, WHO grade, surgery, and chemotherapy) that were used to construct the full Cox model. In addition, LASSO-Cox regression analysis revealed five prognostic factors (age, WHO grade, surgery, radiotherapy, and chemotherapy), and a LASSO model was constructed. A comparison of the two models revealed that the LASSO model with five variables had better predictive performance than the full Cox model with four variables. Ultimately, five key variables based on LASSO-Cox regression were utilized to develop prognostic nomograms for predicting the 1-, 2-, and 5-year OS and CSS rates. The nomograms exhibited relatively good predictive ability and clinical utility. Moreover, the risk stratification system based on the nomograms effectively divided patients into low-risk and high-risk subgroups.Conclusion: Variable screening based on LASSO-Cox regression was used to determine the optimal prediction model in this study. Prognostic nomograms could serve as practical tools for predicting survival probabilities, categorizing these patients into different mortality risk subgroups, and developing personalized decision-making strategies for elderly patients with LGGs. Moreover, the web-based dynamic nomogram could facilitate its use in the clinic.
- Open Access
- 2 July 2024
- Published by Springer Nature in Human Genomics
- Vol. 18 (1) , 74
The cuproptosis-related signature predicts the prognosis and immune microenvironments of primary diffuse gliomas: a comprehensive analysis
Background: Evidence has revealed a connection between cuproptosis and the inhibition of tumor angiogenesis. While the efficacy of a model based on cuproptosis-related genes (CRGs) in predicting the prognosis of peripheral organ tumors has been demonstrated, the impact of CRGs on the prognosis and the immunological landscape of gliomas remains unexplored. Methods: We screened CRGs to construct a novel scoring tool and developed a prognostic model for gliomas within the various cohorts. Afterward, a comprehensive exploration of the relationship between the CRG risk signature and the immunological landscape of gliomas was undertaken from multiple perspectives. Results: Five genes (NLRP3, ATP7B, SLC31A1, FDX1, and GCSH) were identified to build a CRG scoring system. The nomogram, based on CRG risk and other signatures, demonstrated a superior predictive performance (AUC of 0.89, 0.92, and 0.93 at 1, 2, and 3 years, respectively) in the training cohort. Furthermore, the CRG score was closely associated with various aspects of the immune landscape in gliomas, including immune cell infiltration, tumor mutations, tumor immune dysfunction and exclusion, immune checkpoints, cytotoxic T lymphocyte and immune exhaustion-related markers, as well as cancer signaling pathway biomarkers and cytokines. Conclusion: The CRG risk signature may serve as a robust biomarker for predicting the prognosis and the potential viability of immunotherapy responses. Moreover, the key candidate CRGs might be promising targets to explore the underlying biological background and novel therapeutic interventions in gliomas.
- 2 July 2024
- Published by Springer Nature in Human Genomics
- Vol. 18 (1) , 74
Open AccessThe cuproptosis-related signature predicts the prognosis and immune microenvironments of primary diffuse gliomas: a comprehensive analysis
Background: Evidence has revealed a connection between cuproptosis and the inhibition of tumor angiogenesis. While the efficacy of a model based on cuproptosis-related genes (CRGs) in predicting the prognosis of peripheral organ tumors has been demonstrated, the impact of CRGs on the prognosis and the immunological landscape of gliomas remains unexplored. Methods: We screened CRGs to construct a novel scoring tool and developed a prognostic model for gliomas within the various cohorts. Afterward, a comprehensive exploration of the relationship between the CRG risk signature and the immunological landscape of gliomas was undertaken from multiple perspectives. Results: Five genes (NLRP3, ATP7B, SLC31A1, FDX1, and GCSH) were identified to build a CRG scoring system. The nomogram, based on CRG risk and other signatures, demonstrated a superior predictive performance (AUC of 0.89, 0.92, and 0.93 at 1, 2, and 3 years, respectively) in the training cohort. Furthermore, the CRG score was closely associated with various aspects of the immune landscape in gliomas, including immune cell infiltration, tumor mutations, tumor immune dysfunction and exclusion, immune checkpoints, cytotoxic T lymphocyte and immune exhaustion-related markers, as well as cancer signaling pathway biomarkers and cytokines. Conclusion: The CRG risk signature may serve as a robust biomarker for predicting the prognosis and the potential viability of immunotherapy responses. Moreover, the key candidate CRGs might be promising targets to explore the underlying biological background and novel therapeutic interventions in gliomas.